CRSP
Price
$47.91
Change
-$2.52 (-5.00%)
Updated
Feb 21 closing price
Capitalization
4.11B
79 days until earnings call
VERV
Price
$7.28
Change
-$0.55 (-7.02%)
Updated
Feb 21, 04:59 PM (EDT)
Capitalization
616.35M
4 days until earnings call
Ad is loading...

CRSP vs VERV

Header iconCRSP vs VERV Comparison
Open Charts CRSP vs VERVBanner chart's image
CRISPR Therapeutics AG
Price$47.91
Change-$2.52 (-5.00%)
Volume$2.68M
Capitalization4.11B
Verve Therapeutics
Price$7.28
Change-$0.55 (-7.02%)
Volume$36.28K
Capitalization616.35M
CRSP vs VERV Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. VERV commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (CRSP: $50.43 vs. VERV: $7.83)
Brand notoriety: CRSP and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 129% vs. VERV: 66%
Market capitalization -- CRSP: $4.11B vs. VERV: $616.35M
CRSP [@Biotechnology] is valued at $4.11B. VERV’s [@Biotechnology] market capitalization is $616.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 6 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 6 bullish, 4 bearish.
  • VERV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than VERV.

Price Growth

CRSP (@Biotechnology) experienced а +15.96% price change this week, while VERV (@Biotechnology) price change was +1.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

CRSP is expected to report earnings on May 12, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.11B) has a higher market cap than VERV($616M). VERV YTD gains are higher at: 38.830 vs. CRSP (28.125). VERV has higher annual earnings (EBITDA): -219.97M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. VERV (540M). VERV has less debt than CRSP: VERV (71.3M) vs CRSP (228M). CRSP has higher revenues than VERV: CRSP (200M) vs VERV (24.4M).
CRSPVERVCRSP / VERV
Capitalization4.11B616M667%
EBITDA-313.08M-219.97M142%
Gain YTD28.12538.83072%
P/E RatioN/AN/A-
Revenue200M24.4M820%
Total Cash1.94B540M359%
Total Debt228M71.3M320%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPVERV
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 18 days ago
87%
Declines
ODDS (%)
Bearish Trend 13 days ago
84%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TICRX23.02N/A
N/A
Nuveen Large Cap Responsible Eq A
DREQX21.55N/A
N/A
BNY Mellon Research Growth Z
FRSLX27.37N/A
N/A
Nuveen Mid Cap Growth Opps A
TVLAX12.28N/A
N/A
Touchstone Value A
MIEFX13.75N/A
N/A
Matthews Emerging Markets Equity Ins

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-2.97%
BEAM - VERV
53%
Loosely correlated
-2.79%
CRSP - VERV
51%
Loosely correlated
-4.88%
NTLA - VERV
47%
Loosely correlated
-0.24%
PRME - VERV
47%
Loosely correlated
-4.72%
IVEVF - VERV
46%
Loosely correlated
N/A
More